US Stock MarketDetailed Quotes
MBX MBX Biosciences
- 24.000
- +0.450+1.91%
Trading Oct 15 14:05 ET
801.21MMarket Cap-16194P/E (TTM)
24.260High23.055Low56.15KVolume23.820Open23.550Pre Close1.33MTurnover0.55%Turnover RatioLossP/E (Static)33.38MShares26.19052wk High-8.19P/B244.80MFloat Cap20.28552wk Low--Dividend TTM10.20MShs Float26.190Historical High--Div YieldTTM5.12%Amplitude20.285Historical Low23.668Avg Price1Lot Size
MBX Biosciences Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|
| Operating Cash Flow (Indirect Method) | ||
| Cash flow from continuing operating activities | -38.30%-31.98M | -23.12M |
| Net income from continuing operations | -24.60%-32.56M | ---26.14M |
| Operating gains losses | -92.90%69K | --972K |
| Depreciation and amortization | 180.36%157K | --56K |
| Other non cash items | -77.16%95K | --416K |
| Change In working capital | -156.98%-735K | --1.29M |
| -Change in prepaid assets | -32.36%-1.05M | ---791K |
| -Change in payables and accrued expense | -78.47%457K | --2.12M |
| -Change in other current assets | 80.95%-8K | ---42K |
| -Change in other current liabilities | ---137K | --0 |
| Cash from discontinued investing activities | ||
| Operating cash flow | -38.30%-31.98M | ---23.12M |
| Investing cash flow | ||
| Cash flow from continuing investing activities | -171.03%-30.93M | -11.41M |
| Net PPE purchase and sale | 70.75%-129K | ---441K |
| Net investment purchase and sale | -180.75%-30.8M | ---10.97M |
| Cash from discontinued investing activities | ||
| Investing cash flow | -171.03%-30.93M | ---11.41M |
| Financing cash flow | ||
| Cash flow from continuing financing activities | 50.27%69.22M | 46.06M |
| Net issuance payments of debt | --0 | --10M |
| Net preferred stock issuance | 87.74%68.51M | --36.49M |
| Proceeds from stock option exercised by employees | 2,363.33%739K | --30K |
| Net other financing activities | 93.45%-30K | ---458K |
| Cash from discontinued financing activities | ||
| Financing cash flow | 50.27%69.22M | --46.06M |
| Net cash flow | ||
| Beginning cash position | 90.93%24.21M | --12.68M |
| Current changes in cash | -45.25%6.31M | --11.53M |
| End cash Position | 26.08%30.52M | --24.21M |
| Free cash flow | -36.26%-32.11M | ---23.56M |
| Currency Unit | USD | USD |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
